Evidence Hub

Gatifloxacin vs levofloxacin in treatment of urinary tract infections

Zhao Hu

Chinese Journal of New Drugs and Clinical Remedies, 2004

48 participants

Abstract

AIM: To compare the efficacy and safety of gatifloxacin with levofloxacin in the treatment of urinary tract infections. METHODS: Using levofloxacin as a contrast medicine, 48 patients were enrolled to carry out arandomized, double simulation, double blind, parallel controlled trial (n=24) group A was given gatifloxacin 400 mg, qd, for 7-14 d group B (n=24) was given levofloxacin 400 mg, qd, for 7-14 d. RESULTS: The clinical cured rate and effective rate in group A were 100 % and 100 % respectively, and thoses in group B were 92 % and 92 %, respectively. There was no statistical difference between the two groups (P0.05). The bacterial clearance rate was 100 % in two groups, and that was also no significant difference (P0.05). The adverse reaction rates were 8 % and 12 % respectively in group A and B without statistical difference (P0.05). CONCLUSION: The efficacy and safety of gatifloxacin is similar to those of levofloxacin for treatment of urinary tract infections.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free